Dr. Christoph Cichon

No current affiliations available for this person. The person is no longer active at the university.

Publications

MicroRNA-320a Strengthens Intestinal Barrier Function and Follows the Course of Experimental Colitis. Cordes F, Brückner M, Lenz P, Veltman K, Glauben R, Siegmund B, Hengst K, Schmidt MA, Cichon C, Bettenworth D (2016) In: ((Bitte Journal prüfen)), Oct;22(10), 2341-2355. doi:10.1097/MIB.0000000000000917 Research article (journal) \| Peer reviewed \| Published
Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection. Sabharwal H, Cichon C, Ölschläger TA, Sonnenborn U, Schmidt MA. (2016) In: ((Bitte Journal prüfen)), 84(9), 2482-2492. doi:10.1128/IAI.00402-16 Research article (journal) \| Peer reviewed \| Published
MicroRNAs regulate tight junction proteins and modulate epithelial/endothelial barrier functions. Cichon C, Sabharwal H, Rüter C, Schmidt MA. (2014) In: Tissue Barriers, Aug 8;2(4). doi:10.4161/21688362.2014.944446 Research article (journal) \| Peer reviewed \| Published
Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells. Kouzel IU, Pohlentz G, Storck W, Radamm L, Hoffmann P, Bielaszewska M, Bauwens A, Cichon C, Schmidt MA, Mormann M, Karch H, Müthing J (2013) In: Journal of Lipid Research, 54(3), 692-710. doi:10.1194/jlr.M031781 Research article (journal) \| Peer reviewed \| Published
Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells. Kouzel IU, Pohlentz G, Storck W, Radamm L, Hoffmann P, Bielaszewska M, Bauwens A, Cichon C, Schmidt MA, Mormann M, Karch H, Müthing J. (2013) In: ((Bitte Journal prüfen)), 54(3), 692-710. doi:10.1194/jlr.M031781 Research article (journal) \| Peer reviewed \| Published

Show all publications

Projects

Vergleichende Genomanalysen zur Adaptation von Escherichia coli Stamm Nissle 1917 in verschiedenen Wirten. Duration: 01/07/2017 - 30/09/2020 Funded by: Pharma-Zentrale GmbH Type of project: Individual project
A special miRNA as a minimal invasive biomarker for IBD Duration: since 01/01/2012 Type of project: Own resources project